Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* BMI within the range of 19 to 30 kilograms/meters\^2~* Current cigarette smokers who have smoked daily for at least a year, and smoke their first cigarette within 30 minutes of waking up~Exclusion Criteria:~* Participants who have attempted to quit smoking in the last 12 months, are currently attempting to quit smoking or reduce the number of cigarettes they smoke, or are intending to quit smoking in the next 3 months, with or without use of smoking cessation aids~* Treatment with known hepatic enzyme altering agents

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Test nicotine gum (2 mg) (Type: EXPERIMENTAL): A single dose of Nicotine Mint Gum (2 mg) to be chewed.
- Test nicotine gum (4 mg) (Type: EXPERIMENTAL): A single dose of Nicotine Mint Gum (4 mg) to be chewed.
- Reference nicotine gum (2 mg) (Type: ACTIVE_COMPARATOR): A single dose of reference nicotine gum (2 mg) to be chewed.
- Reference nicotine gum (4 mg) (Type: ACTIVE_COMPARATOR): A single dose of reference nicotine gum (4 mg) to be chewed.

Based on this trial design, predict the completion outcome and termination type (if applicable).